![](/img/cover-not-exists.png)
A third of transfusion-dependent patients with myelodysplastic syndromes (MDS) develop alloantibodies against red blood cell antigens
Rozovski, Uri, Ben-Tal, Ofira, Kirgner, Ilya, Mittelman, Moshe, Hareuveni, MaraVolume:
15
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2015.04.116
Date:
June, 2015
File:
PDF, 55 KB
english, 2015